Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study (vol 64, pg 1066, 2021)
Ji, LN; Du, Y; Xu, M; Zhou, XJ; Mo, ZH; Ma, JH; Li, JR; Li, YF; Lin, JN; Wang, YJ; Yang, J; Song, WH; Jin, H; Pang, SG; Liu, H; Li, P; Liu, J; Yao, MX; Li, WH; Jiang, XH; Shen, FX; Geng, HF; Zhou, HF; Ran, JM; Lei, MX; Du, YH; Ye, SD; Guan, QB; Lv, WS; Tan, HW; Chen, T; Yang, JK; Qin, GJ; Li, SY; Chen, L
Ji, LN (corresponding author), Peking Univ Peoples Hosp, Dept Endocrinol, Beijing, Peoples R China.
DIABETOLOGIA, 2021; 64 (8): 1900
